Current Concepts in Multiple Sclerosis
Sixth Congress Proceedings, 1990
Elsevier (Publisher)
Published in May 1991
Book
Hardback
404 pages
978-0-444-81416-6 (ISBN)
Description
In these proceedings of the 6th Congress of the European Committee for Treatment and Research in Multiple Sclerosis three main aspects of the disease are presented and discussed. Early diagnosis: Growing experience in early diagnostic methods raises several problems. When and to what extent should investigations be performed? And should the diagnostic results be revealed to the patient in full detail? Symptomatic treatment: Despite the scarcity of new developments many hospitals neglect the principles of symptomatic treatment or consider them as less important. A review of the basic symptomatic therapy is given. New developments: Therapies under examination (Corticosteroids, Azathioprine and Cyclophosphamide) or experimental therapies (Mitoxantrone) are described and discussed. Vaccination with T-cell receptor epitopes are presented in animals and human experimental settings. The congress contributions reflect research activities in all the major fields of MS. The book is also of considerable interest for neurologists and physicians actively involved in the treatment of MS patients.
In these proceedings of the 6th Congress of the European Committee for Treatment and Research in Multiple Sclerosis three main aspects of the disease are presented and discussed. Early diagnosis: Growing experience in early diagnostic methods raises several problems. When and to what extent should investigations be performed? And should the diagnostic results be revealed to the patient in full detail? Symptomatic treatment: Despite the scarcity of new developments many hospitals neglect the principles of symptomatic treatment or consider them as less important. A review of the basic symptomatic therapy is given. New developments: Therapies under examination (Corticosteroids, Azathioprine and Cyclophosphamide) or experimental therapies (Mitoxantrone) are described and discussed. Vaccination with T-cell receptor epitopes are presented in animals and human experimental settings. The congress contributions reflect research activities in all the major fields of MS. The book is also of considerable interest for neurologists and physicians actively involved in the treatment of MS patients.
In these proceedings of the 6th Congress of the European Committee for Treatment and Research in Multiple Sclerosis three main aspects of the disease are presented and discussed. Early diagnosis: Growing experience in early diagnostic methods raises several problems. When and to what extent should investigations be performed? And should the diagnostic results be revealed to the patient in full detail? Symptomatic treatment: Despite the scarcity of new developments many hospitals neglect the principles of symptomatic treatment or consider them as less important. A review of the basic symptomatic therapy is given. New developments: Therapies under examination (Corticosteroids, Azathioprine and Cyclophosphamide) or experimental therapies (Mitoxantrone) are described and discussed. Vaccination with T-cell receptor epitopes are presented in animals and human experimental settings. The congress contributions reflect research activities in all the major fields of MS. The book is also of considerable interest for neurologists and physicians actively involved in the treatment of MS patients.
More details
Series
Language
English
Place of publication
Oxford
United Kingdom
Publishing group
Elsevier Science & Technology
Target group
College/higher education
Professional and scholarly
Dimensions
Height: 230 mm
Weight
935 gr
ISBN-13
978-0-444-81416-6 (9780444814166)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Content
Welcome address. DIAGNOSIS. Ethics. (2 papers, 2 contributors) Methods. a. MRI (5 papers, 21 con.) b. Spectrometry (2 papers, 11 con.) c. PET (1 paper, 12 con.) d. Neurophysiology (7 papers, 30 con.) e. CSF and serum (13 papers, 53 con.) f. HLA (2 papers, 11 con.) Optic neuritis (2 papers, 12 con.) Neuropsychology (5 papers, 15 con.) SYMPTOMATIC TREATMENT. Ataxia and tremor (2 papers, 2 con.) Spasticity and pain (3 papers, 5 con.) Urinary tract (2 papers, 7 con.) NEW DEVELOPMETS. Therapies under examination. a. Steroids (6 papers, 23 con.) b. Azathioprine/Cyclosporine (2 papers, 9 con.) Experimental therapies. a. Mitoxanthrone (3 papers, 14 con.) b. Sulfosalazine (1 paper, 4 con.) c. Mab (1 paper, 7 con.) d. Irradiation (1 paper, 10 con.) Basic Research (7 papers, 42 con.) Experimental animal research (10 papers, 42 con.) MISCELLANEOUS. (3 papers, 9 con.) Index of authors.